I am a Nurse Practitioner with over a decade at the bedside in Oncology and Critical Care. I transitioned to the Pharmaceutical industry where I started as a CRA and progressed to management as an Early Oncology Global Program Leader and assumed multiple leadership roles as a Clinical Scientist leading multiple early and late phase programs for solid and liquid tumors as well as complex translational medicine and imaging protocols in Oncology drug development trials. Transitioned to Medical Affairs as Medical Science Liaison and internally as Medical Affairs Manager.Specialties: Solid Tumors and tumor specific for Breast, CRC, Lung, HNK, GI, Liver, Melanoma, Ovarian and Renal Renal. HER2 MSL, Clinical Development and Medical Affairs, Thought Leader Development, Pre Clinical Drug Discovery, Early and Late Phase Clinical Research, Oncology, Hematology, Immunology, Immuno-Oncology, Anesthesia, Critical Care, Pain Management, Cardiovascular, Radiology (IR, CA and Imaging), Next Generation Sequencing Expert Early Development Oncology Clinical Scientist and Early Development Program Leader for Small Molecule and MAB including Clinical Pharmacology, Imaging and Translational Medicine, Biomarker sub trials and companion diagnostics. Lead two programs to fast track status for late stage development through project management skill sets and daily hands on clinical site management. Development of associated internal and external training in order to facilitate early review of clinical data and adverse events for Go/No-Go decision making. Selection and management of full service CRO’s with budgetary allocations >25 mill USD and specialty vendors with budgetary allocations < 1 mill USD.Management Strength: Successful collaborator, facilitator and team player with proven track record in building relationships with stakeholders that foster negotiation for “buy in” with national and international cross functional team members in order to meet milestones and decrease cost utilizing PMBoK standards.
